NasdaqCM - Delayed Quote USD

NeuroOne Medical Technologies Corporation (NMTC)

1.0800 +0.0300 (+2.86%)
At close: May 17 at 4:00 PM EDT
1.1200 +0.04 (+3.70%)
After hours: May 17 at 6:01 PM EDT
Loading Chart for NMTC
DELL
  • Previous Close 1.0500
  • Open 1.0500
  • Bid 1.0600 x 100
  • Ask 1.1300 x 100
  • Day's Range 1.0100 - 1.1100
  • 52 Week Range 0.8500 - 2.0000
  • Volume 41,570
  • Avg. Volume 196,393
  • Market Cap (intraday) 28.005M
  • Beta (5Y Monthly) 1.06
  • PE Ratio (TTM) --
  • EPS (TTM) -0.6800
  • Earnings Date Aug 12, 2024 - Aug 16, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 3.15

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

www.n1mtc.com

16

Full Time Employees

September 30

Fiscal Year Ends

Recent News: NMTC

Performance Overview: NMTC

Trailing total returns as of 5/17/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

NMTC
31.65%
S&P 500
11.18%

1-Year Return

NMTC
16.28%
S&P 500
29.04%

3-Year Return

NMTC
83.02%
S&P 500
27.06%

5-Year Return

NMTC
90.77%
S&P 500
84.38%

Compare To: NMTC

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: NMTC

Valuation Measures

Annual
As of 5/17/2024
  • Market Cap

    28.01M

  • Enterprise Value

    25.48M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.70

  • Price/Book (mrq)

    6.34

  • Enterprise Value/Revenue

    9.05

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -109.49%

  • Return on Equity (ttm)

    -214.01%

  • Revenue (ttm)

    2.82M

  • Net Income Avi to Common (ttm)

    -13.47M

  • Diluted EPS (ttm)

    -0.6800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.68M

  • Total Debt/Equity (mrq)

    3.48%

  • Levered Free Cash Flow (ttm)

    -8.61M

Research Analysis: NMTC

Company Insights: NMTC

Research Reports: NMTC

People Also Watch